Physician profile
Felicia Wright
NPI 1568080653
$1,122.86
in general payments reported to CMS, 2019-2025
14 companies · $18.99 in 2025
The $18.99 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $56.58 · 2023: $616 · 2024: $431 · 2025: $18.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $314.44 | 2023-2024 | |
| Glaxosmithkline, LLC. | $175.71 | 2023-2024 | Nucala |
| Amgen INC. | $167.37 | 2022-2024 | Tavneos |
| Pulmonx Corporation | $138.77 | 2023 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Medical Device Business Services, INC. | $121.60 | 2024 | Monarch |
| Genzyme Corporation | $44.20 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $33.50 | 2023 | |
| Merck Sharp & Dohme LLC | $25.72 | 2023 | Lynparza, Keytruda |
| Haemonetics Corporation | $18.99 | 2025 | Teg6s Hemostasis System |
| Takeda Pharmaceuticals U.S.A., INC. | $18.64 | 2024 | |
| Exact Sciences Corporation | $17.08 | 2023 | Cologuard Collection Kit |
| Actelion Pharmaceuticals US, INC. | $17.06 | 2024 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $16.02 | 2022 | |
| Leo Pharma INC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felicia Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.